Assessment of aberrations on chromosome 8 in prostatic atrophy

BJU International

Volumn 98, Issue 1, 2006, Pages 184-188

  Yildiz Sezer, Seval ^a   Verdorfer, Irmgard ^a   Schäfer, Georg ^a   Rogatsch, Hermann ^a   Bartsch, Georg ^a   Mikuz, Gregor ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Chromosome 8; Fluorescence in situ hybridization; Prostate cancer; Prostatic atrophy

Indexed keywords

ARTICLE; CANCER TISSUE; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE ATROPHY; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE EPITHELIUM; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; ATROPHY; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS;

EID: 33745079760     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06233.x     Document Type: Article

References (42)

1. Jemal A Murray T Samuels A Ghafoor A Ward E Thun MJ. Cancer statistics, 2003. CA Cancer J Clin 2003 53: 5 26
2. Horninger W Berger A Pelzer A et al. Screening for prostate cancer: updated experience from the Tyrol study. Curr Urol Rep 2004 5: 220 5
3. Carter BS Beaty TH Steinberg GD Childs B Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 1992 89: 3367 71
4. Nelson WG De Marzo AM Isaacs W. Prostate cancer. N Engl J Med 2003 349: 366 81
5. Franks LM. Atrophy and hyperplasia in the prostate proper. J Pathol Bacteriol 1954 68: 617 21
6. De Marzo AM Marchi VL Epstein JI Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 1999 155: 1985 92
7. Ruska KM Sauvageot J Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol 1998 22: 1073 7
8. Postma R Schroder FH van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationships to prostate cancer incidence in screened men. Urology 2005 65: 745 9
9. Billis A. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol 1998 11: 47 54
10. Billis A Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Arch Pathol Lab Med 2003 127: 840 4
11. McNeal JE. Normal histology of the prostate. Am J Surg Pathol 1988 12: 619 33
12. Cheville JC Bostwick DG. Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol 1995 19: 1068 76
13. Feneley MR Young MP Chinyama C Kirby RS Parkinson MC. Ki-67 expression in early prostate cancer and associated pathological lesions. J Clin Pathol 1996 49: 741 8
14. Macoska JA Trybus TM Wojno KJ. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology 2000 55: 776 82
15. Shah R Mucci NR Amin A Macoska JA Rubin MA. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 2001 158: 1767 73
16. Bova GS Carter BS Bussemakers MJ et al. Homozygous deletion in frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 1993 53: 3869 73
17. Kagan J Stein J Babaian RJ et al. Homozygous deletions at 8p22 and 8p21 in prostate implicate these regions as the sites for candidate tumour suppressor genes. Oncogene 1995 11: 2121 6
18. Jenkins R Takahashi S DeLacey K Bergstralh E Liber M. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer. Genes Chromosomes Cancer 1998 21: 131 43
19. Bostwick DG Shan A Qian J et al. Independent origin of multiple foci of prostatic intraepithelial neoplasia: comparison with matched foci of prostate carcinoma. Cancer 1998 83: 1995 2002
20. Cher ML MacGrogan D Bookstein R Brown JA Jenkins RB Jensen RH. Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer 1994 11: 153 62
21. Visakorpi T Kallioniemi AH Syvanen AC et al. Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995 55: 342 7
22. Van den Berg C Guan XY Von Hoff D et al. DNA sequence amplification in human prostate cancer identified by chromosome microdissection: potential prognostic implications. Clin Cancer Res 1995 1: 11 8
23. Nupponen NN Kakkola L Koivisto P Visakorpi T. Genetic alterations in hormone refractory recurrent prostate carcinomas. Am J Pathol 1998 153: 141 8
24. Sato K Qian J Slezak M et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J Natl Cancer Inst 1999 91: 1574 80
25. Macoska JA Beheshti B Rhim JS et al. Genetic characterization of immortalized human prostate epithelial cell cultures. Evidence for structural rearrangements of chromosome 8 and i(8q) chromosome formation in primary tumour derived cells. Cancer Genet Cytogenet 2000 120: 50 7
26. Jenkins RB Qian J Lieber MM Bostwick DG. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res 1997 57: 524 31
27. Sobin LH Wittekind Ch eds., TNM Classification of Malignant Tumours, 6th edn. New York: Wiley-Liss Inc, 2002: 172 5
28. Kononen J Bubendorf L Kallioniemi A et al. Tissue microarrays for high throughput molecular profiling of tumour specimens. Nat Med 1998 4: 844 7
29. Chin SF Daigo Y Huang HE et al. A simple and reliable pretreatment protocol facilities fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples. Mol Pathol 2003 56: 275 9
30. Nelson WG De Marzo AM DeWeese TJ Isaacs WB. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004 172: S6 12
31. Nakayama M Bennett CJ Hicks JL et al. Hypermethylation of the human glutathione S-transferase-pi-gene (GSTP1) islands is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 2003 163: 923 33
32. Hussain T Gupta S Mukhtar H. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 2003 191: 125 35
33. Anton RC Kattan MW Chakraborty S Wheeler TM. Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Surg Pathol 1999 23: 932 6
34. Tsuchiya N Slezak JM Lieber MM Bergstralh EJ Jenkins RB. Clinical significance of alterations of chromosome 8 detected by fluorescence in situ hybridisation analysis in pathologic organ-confined prostate cancer. Genes Chromosomes Cancer 2002 34: 363 71
35. Macoska JA Trybus TM Benson PD et al. Evidence for three tumour suppressor gene loci on chromosome 8 in human prostate cancer. Cancer Res 1995 55: 5390 5
36. Matsuyama H Pan Y Oba K et al. The role of chromosome 8p22 deletion for predicting disease progression and pathological staging in prostate cancer. Aktuelle Urol 2003 34: 247 9
37. Gonzalgo ML Isaacs WB. Molecular pathways to prostate cancer. J Urol 2003 170: 2444 52
38. Narita S Tsuchiya N Wang L et al. Association of lipoprotein lipase gene polymorphism with risk of prostate cancer in a Japanese population. Int J Cancer 2004 112: 872 6
39. Maier C Vesovic Z Bachmann N et al. Germline mutations of MSR1 gene in prostate cancer families from Germany. Hum Mutat 2006 27: 98 102
40. De Marzo AM Nelson WG Isaacs WB Epstein JI. Pathological and molecular aspects of prostate cancer. Lancet 2003 361: 955 64
41. Gil J Kerai P Lleonart M et al. Immortalization of primary human prostate epithelial cells by c-Myc. Cancer Res 2005 65: 2179 85
42. Bernard D Poutier-Manzanedo A Gil J Beach DH. Myc confers androgen-independent prostate cancer cell growth. J Clin Invest 2003 112: 1724 31